Established Asset · AI-driven longevity science tracker (biological age, drug discovery, senolytics)

AgeLifeForward.com

agelifeforward.com is the technical, science-facing lane of longevity ... biological age, drug discovery, senolytics ... a category with heavy capital behind it and no dominant independent brand. There is a built hub with reference datasets on the domain already. It sells as the name and the position; a buyer sets the depth and the business model. Built, live.

Maker's Notes

A considered acquisition for a buyer who values aI-driven longevity science tracker (biological age, drug discovery, senolytics). The clearest documented next step is build the Phase 2 databases (therapies, longevity companies, biomarker expansion), assessed in the passport as high impact with medium effort.

Cellar Notes

Built, live. No current-site traffic documented. The source passport was verified 2026-08-28 against 6 documented sources.

Tasting Notes

Investor Appeal
Strong
Growth Profile
High
Authority Potential
Moderate
Hold Type
Long-term hold

Digital Asset Provenance

Aging Notes

  • Built, live.
  • Passport verified 2026-08-28

Production Notes

  • Build the Phase 2 databases (therapies, longevity companies, biomarker expansion)
  • Test whether the historical 'age reversal' measured visibility transfers to the rebuilt site
  • Align .htaccess with the portfolio-canonical block rule
Niche AI-driven longevity science tracker (biological age, drug discovery, senolytics)
Status Available
Monetization Pre-revenue, plan not yet confirmed live

Private Acquisition Notes

Get early access to curated SEO website opportunities.

A private list for serious acquirers. No noise.

No spam. Unsubscribe any time.